NEW YORK — Shoreline Biome said on Thursday that it has signed an agreement to distribute its microbiome research products and services in sub-Saharan Africa through Inqaba Biotechnical Industries.
Financial and other terms of the deal were not disclosed.
Shoreline, founded in 2015, offers all-in-one microbiome assay kits, as well as related analysis software, designed to work on long-read Pacific Biosciences and Oxford Nanopore sequencing platforms and Illumina's short-read sequencing platform.
Inqaba Biotec, based in South Africa with offices in Ghana, Kenya, Nigeria, Tanzania, and Senegal, distributes a range of life science and molecular diagnostics products. It will also use Shoreline's products to offer strain identification services to microbiome researchers on its PacBio system.
In early 2018, Farmington, Connecticut-based Shoreline raised $1.1 million in private funding.